Dr. Wang has provided statistical support to investigators in health behaviors and community health studies, psychology, health policy, and pediatrics. She is interested in the design and analysis of clinical trials, survival analysis with a focus on accommodating competing risks, propensity score analysis, multiple imputation technique to handle missing data, and measurement invariance testing in psychological and developmental research.
- BS, Chemistry, Jilin University, 2005
- MS, Biochemistry, Purdue University, 2009
- PhD, Biostatistics, University of Pittsburgh, 2015
Education & Training
Snitz BE, Wang T, Cloonan YK, Jacobsen E, Chang CH, Hughes TF, Kamboh MI, Ganguli M. Risk of progression from subjective cognitive decline to mild cognitive impairment: The role of study setting. Alzheimers Dement. 2018; 14(6):734-742.
Wu F, Wang T. Risk assessment of upper tract urothelial carcinoma related to aristolochoic acid. Cancer Epidemiol Biomarkers Prev. 2013; 22(5):812-820.
Snitz BE, Small BJ, Wang T, Chang CH, Hughes TF, Ganguli M. Do subjective memory complaints lead or follow objective cognitive change? A five-year population study of temporal influence. J Int Neuropsychol Soc. 2015; 21(9):732-742.
